|
HS Code |
822996 |
| Product Name | Benzyl N-(4-Aminobutyl)Carbamate Hydrochloride |
| Cas Number | 1193400-94-9 |
| Molecular Formula | C12H19ClN2O2 |
| Molecular Weight | 258.75 g/mol |
| Appearance | White to off-white solid |
| Purity | Typically ≥98% |
| Solubility | Soluble in water and DMSO |
| Storage Temperature | 2-8°C (refrigerated) |
| Synonyms | Carbamic acid, (4-aminobutyl)-, phenylmethyl ester, hydrochloride |
| Smiles | C1=CC=C(C=C1)COC(=O)NCCCCN.Cl |
| Inchikey | CRCZALHZJBDZKZ-UHFFFAOYSA-N |
As an accredited Benzyl N-(4-Aminobutyl)Carbamate Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Sealed 10g amber glass vial with white screw cap, labeled with chemical name, formula, hazard symbols, batch number, and storage instructions. |
| Shipping | Benzyl N-(4-Aminobutyl)carbamate hydrochloride is shipped in secure, tightly sealed containers to prevent moisture and contamination. It is packed according to standard chemical safety regulations and transported at ambient temperature unless otherwise specified. Packaging includes appropriate labeling with hazard information and documentation for safe handling and regulatory compliance during transit. |
| Storage | Benzyl N-(4-Aminobutyl)carbamate hydrochloride should be stored in a tightly sealed container, protected from light and moisture. Keep it in a cool, dry, and well-ventilated location, preferably at 2–8°C (refrigerator temperature). Ensure storage away from incompatible substances such as strong acids and oxidizers. Proper labeling and adherence to safety guidelines are essential to prevent degradation or hazardous reactions. |
Applications of Benzyl N-(4-Aminobutyl)Carbamate Hydrochloride in Industrial ManufacturingManufacturers across the fine chemicals sector use Benzyl N-(4-Aminobutyl)Carbamate Hydrochloride in complex synthesis processes where precision and regulatory compliance are crucial. Below, we detail the main industrial application scenarios, covering specific compliance requirements, realistic usage ratios, integration points, and the primary finished products produced by our global customers. 1. Active Pharmaceutical Ingredient (API) Intermediate for CNS Drug SynthesisPharmaceutical companies employ this compound as a protected amine intermediate during the multi-step synthesis of central nervous system (CNS) agents, notably GABAergic drugs. The intermediate’s protective group chemistry allows precise deprotection under standard hydrogenation at later synthesis stages, minimizing side reactions and impurity profiles. Validation batches follow stringent cGMP batch records, and the material’s residual solvent and impurity levels must match ICH guidelines. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Monomer Modifier in Polyamide and Polyurethane R&DSpecialty polymer manufacturers use this carbamate-protected diamine as a chain-terminating or functional monomer modifier during the synthesis of polyamide and polyurethane elastomers. The free amine is released under controlled acidic or catalytic conditions during post-polymerization modification, allowing precision placement of butyl-functional groups within the polymer matrix. Strict traceability and resin batch-level documentation are maintained to satisfy downstream customer audits and meet specific technical data sheet (TDS) specifications. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Custom-Built Ligand Intermediate in Industrial CatalysisCatalyst development firms use Benzyl N-(4-Aminobutyl)Carbamate Hydrochloride as an intermediate for constructing bulky N-donor ligands for transition metal-catalyzed hydrogenation or cross-coupling reactions. The protected amine enables selective functionalization at the nitrogen site prior to final deprotection, simplifying ligand library development. Laboratory and pilot scale operators must meet ISO guidelines for chemical processing, and strict in-process analytical controls are maintained to assure ligand identity and purity. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Intermediate for Fluorescent Dye Synthesis in Biotechnical ApplicationsManufacturers of specialty fluorescent reagents employ this protected aminobutyl carbamate in the staged manufacture of cationic fluorescent dyes used for DNA/RNA labelling and live-cell imaging. The chemically stable protective group enables multistep synthesis, valuable for introducing alkyl chains without premature amine side reactions or quenching during subsequent aromatic substitution. Each lot is traceable, and quality control follows the standards required for diagnostic or cell biology reagents. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Benzyl N-(4-Aminobutyl)Carbamate Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Working in chemical manufacturing keeps you close to the way molecules shape lives and industries. Among our current specialty products, Benzyl N-(4-Aminobutyl)Carbamate Hydrochloride stands out for its structure and practical application. Coming off our reactors in fine, dense crystals, it supports a range of process chemistries, primarily in pharmaceutical research.
Our technical team refers to this compound by its model number—often abbreviated as BAC-HCl within the plant—so for clarity, that's how we’ll refer to it here. BAC-HCl has gotten attention lately because it reliably serves as a protected aminobutyl group in peptide synthesis and organic transformations. The molecular formula (C12H18ClN3O2) and the proper balancing of the carbamate, benzyl, and aminobutyl segments give it a stability profile that carries through during storage, handling, and use.
BAC-HCl leaves our line as a white-to-off-white crystalline powder with purity tested at over 99% by HPLC. Our team checks every batch; this isn’t a hands-off, remote operation. Each kilogram gets weighed, packaged, and archived with full analytical records, so process researchers receive consistent results every time. The HCl salt increases solubility in common solvents and increases the compound’s handling safety compared with the free base form. We’ve noted that researchers appreciate not having to neutralize free amine vapors—or troubleshoot unwanted reactions due to the instability of less protected analogs.
Benzyl N-(4-Aminobutyl)Carbamate Hydrochloride regularly plays a key role in small-molecule synthesis and combinatorial chemistry. On the R&D side, scientists take advantage of its carbamate-protected amine, unlocked only when needed. During SPPS (solid-phase peptide synthesis), the protected aminobutyl tail allows for orthogonal deprotection steps, yielding clean downstream amide bond formation.
Beyond drug discovery, BAC-HCl appears in the synthesis of peptide-mimic drugs, enzyme substrates, or even as a reagent for linker studies in bioconjugation. Our interactions with pharma labs reveal how its protected group outcompetes direct amine counterparts. Chemical researchers know that skipping amine protection means facing aggressive byproducts or capping events, which introduces risk and re-work. By supplying the protected form, a consistent route to higher yields and safer workups becomes available, and fewer projects hit an impasse early.
In diagnostic kit assembly, BAC-HCl makes appearances as a building block for engineered molecules. Researchers trust it to maintain biological activity of active sites through each workup due to the stable, removable protection. This reliability gives medicinal chemists and protein engineers some breathing room when developing candidate molecules. Even small irregularities—moisture content, excess salt, or low purity—can create chain reactions in these workflows, and plant teams know the value of strict in-process monitoring for each batch.
Chemists ask how BAC-HCl differs from open-chain amino acids, regular aminobutyl carbamate, or commercial variants with methyl, ethyl, or tert-butyl tweaks. The benzyl group offers predictable deprotection—in hydrogenolysis, for example—so after synthesis, this group can be taken off without collateral damage to sensitive functional groups nearby. Plant observations show that methyl or tert-butyl carbamates sometimes trade ease of removal for increased side reactions during hydrogenation or acidolysis, which BAC-HCl manages to avoid.
Compared to free base forms or similar salts, BAC-HCl offers sharper melting points and cleaner spectral profiles. Recrystallization from isopropanol or ethyl acetate yields substantial batch recovery, and experienced operators can spot impurities early by the way the product behaves in solvent, not just by machine readout. Having partnered with academic labs, we’ve seen how these differences influence route selection and purification strategy.
The hydrochloride salt’s moisture stability sets it apart from other forms. Our process operators have noticed that BAC-HCl’s loss-on-drying remains lower across varied humidity, a benefit for anyone storing material long-term or working without perfect climate control. This is more than convenience—it minimizes risk of hydrolysis or degradation during storage and transit. Peptide chemists compare this to the more labile mesylate, tosylate, or unprotected amine salts that pick up water, darken, or even polymerize under identical storage.
As the original manufacturer, we’ve seen no substitute for purpose-built reactors, fresh raw materials, and the watchful eye of technicians who know this product by sight and smell. BAC-HCl comes through a validated environment, which includes air and material handling protocols, modern crystallizers, and in-line purification. Batches don’t sit around; each one receives rapid turnover, reducing thermal exposure and minimizing side-product accumulation.
On the analytical floor, the QC team spends real hours on every lot. NMR, FTIR, HPLC, and GC-MS provide multidimensional product mapping. The spectral fingerprints match up with documented reference data, and we keep reference lots under argon for long-term assurance. Any outlier triggers full retesting and, if necessary, reprocessing or rejection. This direct control over synthesis and purification makes correction possible—no one relabels an inferior batch simply because an order needs to ship.
Because we hold control over every stage—from charge to packing—the path from base chemicals to shipping carton remains transparent. Full chain of custody, batch documentation, and pre-shipment COA copies stay with the shipment. This isn’t a hands-off, bulk-resale operation; customers can trace any issue to our plant and reach the technical chemist in charge of their batch.
Producing BAC-HCl to high standards takes more than know-how. Sourcing benzyl chloroformate with strictly limited impurities becomes tricky in tight supply years. Aminobutylamine also arrives with batch-to-batch variation; even minor differences in chain-length impurities translate into off-specification material if not tested and purged early. Over years at the plant, we’ve developed supply contracts with upstream partners who match our standards. When one supplier’s shipment fails tight purity screens, we choose a longer lead time over shortcutting this step.
Downstream, the process team faces solvent recovery, waste stream management, and batch-to-batch reproducibility as practical concerns. Solvents like dichloromethane and ethyl acetate can generate compliance headaches if not recycled properly. We have installed solvent distillation columns and vapor recovery on our lines, both for waste cost and for worker health. The sector increasingly rewards closed-loop operation, and regulators expect this level of commitment. Making promises and skipping these upgrades might sell more in the short term, but in the long run, it puts product, people, and the planet at risk.
Many years ago, BAC-HCl was mostly a specialty item. Now, as modular chemical synthesis gains traction, regulatory oversight has ramped up. Modern pharma clients demand assurance on purity, trace metals, residual solvents, and elemental impurities. Each order goes out with a full analytical breakdown. Law requires compliance with REACH, TSCA, and other local chemical regulations. Periodic audits by health authorities confirm compliance with GMP-like principles, even for R&D-grade products. Inspector walk-throughs check batch records, safety drills, air quality logs, and employee training records.
There have been times when authorities updated acceptable levels of byproducts or required new risk assessments. We reorganized product documentation and invested in new segregation bins for non-compliant waste. Staff attend annual update courses, and our plant’s incident logs shape worker training. Some see compliance as red tape, but these rules protect operators, customers, and the downstream public.
As manufacturers, we face scrutiny on where raw materials originate. Several clients ask about conflict minerals, fair labor, and local sourcing. We built supply tracker systems as part of continuous improvement, helping identify non-ethical upstream sources before procurement. Suppliers receive questionnaires, and feedback flows both directions so that risks get flagged long before they become critical. Unethical practices upstream become risks for everyone downstream, so cutting them out at the source makes sense from both an ethical and a business standpoint.
This transparency builds trust—not just with major clients but with smaller biotech and academic groups who lack leverage to demand compliance. Smaller clients, in particular, appreciate deeper detail on the origins and handling of specialty chemicals. Their researchers want confidence that every component in their chain of synthesis has met basic environmental and human-rights standards. By tracing the route from raw materials through the reactor, we lend visible assurance that their models, data, and publications rest on solid ground.
Markets shift. New applications for BAC-HCl emerge every year, along with more rigorous analytical demands. Years ago, clients mostly worked with UV detection and melting points; now they expect mass spec, nitrogen analysis, detailed photostability data. As a plant team, we didn’t just react to this change. Instead, we developed internal data archives, cross-referencing client feedback with processing notes to pinpoint trends and predict issues.
For instance, an uptick in peptide analog projects led us to re-examine trace inorganic salt residues left after final crystallization. Adjusting the solvent ratio shaved excess sodium below critical thresholds, meeting stricter detection limits. Open channels to client R&D teams enable focused problem-solving—one-to-one, not one-size-fits-all.
Collecting both formal and informal client feedback shapes next runs. Process improvements are logged and reviewed, not just implemented ad hoc. Clients don’t want to see shifts in trace impurities, melting points, or color without warning. That consistency only comes from ongoing plant investment and a willingness to revisit assumptions about process chemistry and quality control.
Manufacturing chemicals like BAC-HCl isn’t simply about order fulfillment. Every operator brings years of specific chemical handling background. Rotating staff from other lines builds cross-knowledge, but core plant experts remain constant, keeping every shift aligned. Training extends from hands-on apprenticeships to group review of new analytical techniques.
Documentation keeps mistakes rare. Every key step is logged: charge in, stir timing, temperature points, solvent swap, pH adjustment, filtration, drying curves. Management reviews every deviation, requiring root-cause analysis rather than finger-pointing. This rigor means customers receive a detailed pedigree for every delivered batch.
Several years ago, one run of BAC-HCl showed unexpected color and minor performance differences. Tracking back through detailed logs, the cause emerged: a slightly out-of-spec filter caused micro-particulate carryover. Since then, we have implemented closer pre-filter checks and longer post-drying stabilization—all driven by front-line experience, not desk mandates. This feedback loop creates improvements that become standard practice, locking in better reliability with every subsequent run.
Buying BAC-HCl from a manufacturer gives research teams a direct line to troubleshooting tips, batch data, and product support. Distributors and traders can’t offer this depth. Researchers who have gotten varying results from generic, relabeled, or resold material relate how batch-specific quirks can throw off complex syntheses.
Here, each technical contact knows who handled every stage of the synthesis and packaging. We take calls from the lab bench, providing recommendations on solvent selection, dissolution process, or protection group compatibility. This relationship ensures that when issues arise, researchers can reach the source and receive data-driven guidance instead of generic instructions copied from a datasheet.
BAC-HCl ships in sealed, moisture-proof containers. Plant staff train logistics teams to spot container flaws and verify atmosphere during packaging. Climatic controls and temperature monitoring reduce exposure to high humidity, limiting caking or hydrolysis. These precautions derive from real process lessons, not simply regulatory mandates.
We maintain climate records on every outgoing shipment. If customers notice handling or purity anomalies, our records help trace root causes. As physical product goes out, digital documentation and sample reserves are archived in case any discrepancies turn up. We’ve seen first-hand how neglecting this attention can derail months of research or development, so thoroughness in storage, shipping, and record-keeping is not negotiable.
With new demands from increasingly sophisticated R&D clients, the story of BAC-HCl extends beyond reliable delivery. We stay open to adjusting specifications, investing in tighter analytical methods, and working collaboratively with research partners. Whether the next innovation targets drug compounds, diagnostic intermediates, or next-generation polymers, BAC-HCl continues to provide a reliable platform for creating, testing, and scaling modern molecules.
Choosing to work directly with a dedicated manufacturer means gaining transparent oversight, direct technical support, and a shared commitment to continual process improvement. Our team looks forward to collaborating with new and established partners who value the depth that plant-side experience brings to each batch—and each breakthrough.